| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8743808 | Transplant Immunology | 2018 | 38 Pages |
Abstract
Given the high prevalence of AT1R-Ab pre-transplant (20%) and its association with dnDSA and early TCMR, a prospective study to determine if more intense immunosuppression and/or AT1R blockade has an impact on outcomes in these patients is warranted.
Keywords
Microvascular inflammationABSMFIABMRPTCAT1RTCMRETARDSAMVIperitubular capillaritisglomerulitisDonor-specific antibodyantibodiesHuman leukocyte antigenHLAangiotensin II type 1 receptorInterstitial inflammationtubulitisantibody-mediated rejectionAcute rejectionmean fluorescent intensityAntibodyendothelin type A receptor
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Alison J. Gareau, Chris Wiebe, Denise Pochinco, Ian W. Gibson, Julie Ho, David N. Rush, Peter W. Nickerson,